SCHEMBL4853087

SCHEMBL4853087

Cc1ccc(N=C(N)c2ccc(S(C)(=O)=O)cc2)cc1C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIN2B Q13224 1/20 0.46
PTGS2 P35354 3/20 0.41
CYP2D6 P10635 1/20 0.41
HIF1A Q16665 1/20 0.41
KMT2A Q03164 3/20 0.39
LMNA P02545 2/20 0.39
GFER P55789 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
BRD4 O60885 1/20 0.39
ALDH1A1 P00352 2/20 0.39
MAPT P10636 2/20 0.39
PRSS1 P07477 1/20 0.38
PRSS2 P07478 1/20 0.38
PRSS3 P35030 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
MEN1 O00255 2/20 0.37
USP2 O75604 1/20 0.37
RAB9A P51151 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
HSD17B10 Q99714 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4854998 0.83 CYP2D6 (0.60) GRIN2BPTGS2CYP2D6HIF1AKMT2A
SCHEMBL5595201 0.83 CYP2D6 (0.60) GRIN2BPTGS2CYP2D6HIF1AKMT2A
SCHEMBL5593828 0.82 PTGS2 (0.45) GRIN2BPTGS2CYP2D6HIF1APRSS1
SCHEMBL5594052 0.79 PTGS2 (0.51) GRIN2BPTGS2CYP2D6HIF1AALDH1A1
SCHEMBL5698495 0.79 PTGS2 (0.51) GRIN2BPTGS2PRSS1PRSS2PRSS3
SCHEMBL5594336 0.79 PTGS2 (0.51) GRIN2BPTGS2PRSS1PRSS2PRSS3
SCHEMBL5593941 0.79 PTGS2 (0.51) GRIN2BPTGS2CYP2D6HIF1AALDH1A1
SCHEMBL5593964 0.78 MEN1 (0.61) GRIN2BPTGS2CYP2D6HIF1AKMT2A
SCHEMBL4862318 0.78 KMT2A (0.60) CYP2D6HIF1AKMT2ALMNAGFER
SCHEMBL8557221 0.77 GRIN2B (0.46) GRIN2BPTGS2CYP2D6HIF1AKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7365069-B2 Pyrimidone derivatives BEXEL PHARMACEUTICALS INC. (US) 2008-04-29 US disclosed
US-20040259891-A1 Novel pyrimidon derivatives ORCHID CHEMICAL & PHARMACEUTICALS LIMITED (IN) 2004-12-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040259891-A1 Novel pyrimidon derivatives TYMS, TPMT, TYMP GRIN2B 993/4885PTGS2 1957/4885CYP2D6 16/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.